Refresh

LUPIN LTD. - Lupin Receives FDA Approvals for Generic Vfend Tablets 50mg, 200mg & Vfend Oral Suspension, 40 mg/mL


Download
06 Jun 2016
Lupin Ltd has informed BSE regarding a Press Release dated June 06, 2016 titled "Lupin Receives FDA Approvals for Generic Vfend Tablets 50mg, 200mg & Vfend Oral Suspension, 40 mg/mL".

Source: BSE India

View all announcements for LUPIN LTD.
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com